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Albeit the pathogenesis of COVID-19 remains unclear, host’s genetic polymorphisms
in genes involved in infection and reinfection, inflammation, or immune stimulation
could play a role in determining the course and outcome. We studied in the early
phase of pandemic consecutive patients (N = 383) with SARS-CoV-2 infection,
whose subsequent clinical course was classified as mild or severe, the latter being
characterized by admission to intensive therapy unit or death. Five host gene
polymorphisms (MERTK rs4374383, PNPLA3 rs738409, TLL-1 rs17047200, IFNL3
rs1297860, and INFL4 rs368234815) were assessed by using whole nucleic acids
extracted from nasopharyngeal swabs. Specific protease cleavage sites of TLL-
1 on the SARS-CoV-2 Spike protein were predicted in silico. Male subjects and
older patients were significantly at higher risk for a severe outcome (p = 0.02 and
p < 0.001, respectively). By considering patients ≤65 years, after adjusting for potential
confounding due to sex, an increased risk of severe outcome was found in subjects
with the GG genotype of PNPLA3 (adj-OR: 4.69; 95% CI = 1.01–22.04) or TT genotype
of TLL-1 (adj-OR=9.1; 95% CI = 1.45–57.3). In silico evaluation showed that TLL-1
is potentially involved in the Spike protein cleavage which is essential for viral binding
and entry into the host cells using the host receptor angiotensin-converting enzyme 2
(ACE2). Subjects carrying a GG genotype in PNPLA3 gene might have a constitutive
upregulation of the NLRP3 inflammasome and be more prone to tissue damage when
infected by SARS-CoV-2. The TT genotype in TLL-1 gene might affect its protease
activity on the SARS-CoV-2 Spike protein, enhancing the ability to infect or re-infect
host’s cells. The untoward effect of these variants on disease course is evident in
younger patients due to the relative absence of comorbidities as determinants of
prognosis. In the unresolved pathogenetic scenery of COVID-19, the identification of
genetic variants associates with more prolonged course or with a severe outcome of
infection would support the development of predictive tools useful to stratify subjects by
risk class at presentation. Moreover, the individuation of key genes could contribute to a
better understanding of the pathways involved in the pathogenesis, giving the basis for
rational therapeutic approaches.
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INTRODUCTION
More than 140 million cases of infection with Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) have been
reported worldwide by April 19, 2021, with over 3 million deaths
due to the virus (World Health Organization, 2020 coronavirus
disease situation dashboard. Available at1). While the clinical
spectrum is extremely broad, ranging from mild or asymptomatic
cases to severe acute respiratory syndrome, it has become
immediately apparent that the outcome of infection is strongly
conditioned by host-related factors such as age, gender and
preexistent underlying illnesses. In the setting of RNA virus with
a relatively fast evolutionary rate (Li et al., 2020) no clear evidence
has instead emerged up to now for viral variability as a major
determinant of pathogenicity. SARS-CoV-2 viral load, although
linked to the phase of infection, does not appear to be a major
determinant of pathogenicity even if a precise quantification of
viral load in samples from oropharyngeal swabs remains elusive
(Joynt and Wu, 2020).
Albeit the pathogenetic mechanism of coronavirus disease
2019 (COVID-19) is yet partly unclear, the course and outcome
of disease seem to be significantly influenced by host factors.
Although the role of virally driven hyperinflammation inducing
a massive release of cytokines leading to a “Cytokine storm”
is controversial (Sinha et al., 2020), the role of inflammatory
processes in COVID-19 severity, especially in patients with
comorbidities, is generally accepted (De la Rica et al., 2020).
Since family clustering of severe cases was reported starting from
the first phase of the pandemic, supporting the possibility of a
genetic predisposition (Chan et al., 2020), it is thus conceivable
that the complexity of host genetic background in terms of
polymorphisms, may play a key role in pathogenesis and outcome
of COVID-19. In this perspective, the COVID-19 Host Genetics
Initiative, 2020 (available at COVID-19 HGI2) is currently leading
a public effort worldwide to analyze COVID-19 information for
millions of individuals in relation with genotype data to identify
genetic variants associated with SARS-CoV-2 infection as well as
COVID-19 hospitalization and disease severity (COVID-19 Host
Genetics Initiative, 2020).
Several data arise from Genome-Wide Association study
(GWAS) which, moreover, are not far from criticisms leading
sometimes to the identification of variants that have not direct
biological relevance to disease pathogenesis and being, on
the other hand, not always able to discover all the variants
involved in disease occurrence and progression (Tam et al.,
2019). In this perspective together to GWAS, studies of
candidate genes and cohort studies are still useful nowadays and
this paper aims to evaluate Single Nucleotide Polymorphisms
(SNP) in genes, whose products are known to interact
with SARS-CoV-2 receptor-dependent endocytosis or involved
in antiviral responses and inflammation conditioning host
response to the virus.
We aimed to assess some specific functional SNPs of
genes involved in control of viral infection by induction
1https://covid19.who.int/
2https://www.covid19hg.org/
of inflammation (IFNL3/IFNL4), in macrophage polarization
(MERTK), in tissue and systemic inflammation (PNPLA3). In
addition, we evaluated a SNP of Tolloid Like-1 (TLL-1), a secreted
protease capable of activating complement through the C1q
pathway and also potentially able to activate the Spike protein
of SARS-CoV-2. These SNPs were investigated on DNA samples
directly derived from oropharyngeal swabs collected from a
cohort of SARS-CoV-2 patients, from Sicily, Southern Italy, at the
onset of the pandemic phase.
MATERIALS AND METHODS
Our observational study was carried out from February 24, 2020
to April 8, 2020 and included all consecutive Sicilian patients
(N = 383) with laboratory-confirmed SARS-CoV-2 infection,
whose oropharyngeal or nasopharyngeal swabs had been sent to
the referral Laboratory for COVID-19 Surveillance for Western
Sicily located at University Hospital “P. Giaccone” of Palermo.
An approval to conduct the study has been required and obtained
from the Ethical Committee of the A.O.U.P. “P. Giaccone” of
Palermo, Italy (AIFA CE 150109 n. 03/2021).
Laboratory confirmation for SARS-CoV-2 was defined as
a positive result of reverse transcriptase real-time polymerase
chain reaction (rtReal-Time PCR) of nasal, pharyngeal or
nasopharyngeal swabs according to the Centers for Disease
Control and Prevention, 2020 protocol3. For each patient,
sociodemographic variables (age, sex, and residency) were
collected at the baseline, whereas clinical outcomes [home
isolation, hospitalization, admission to intensive care unit (ICU),
and death] were obtained by consulting the clinical profiles
centrally provided by the Italian National Institute of Health
(Istituto Superiore di Sanità, ISS) and, when available, by direct
contact with the Hospitals involved in the care of each recruited
patient. Each patient was monitored for at least 21 days after
recruitment and the final day of follow-up was April 8, 2020.
Due to the observational design, linked to referral, no follow up
biological samples were available. Relatives were excluded from
the cohort a priori.
SNP Genotyping
Single Nucleotide Polymorphisms genotyping was carried out
in 383 patients on the extracted whole nucleic acids from
nasal or pharyngeal swabs (QIAamp Viral RNA Mini Kit,
QIAGEN) by TaqMan genotyping allelic discrimination method
(StepOne Plus Real Time PCR System, A.B. Foster City,
CA, United States) using commercial (MERTK rs4374383,
PNPLA3 rs738409, TLL-1 rs17047200) or custom (IFNL3
rs1297860, INFL4 rs368234815) genotyping assays (Thermo
Fisher Scientific). Complete genotyping was not possible for all
patients due to the scarce amount DNA available from swabs. The
genotyping call was done by 2.3 Applied Biosystems Software.
Genotyping was conducted in a blinded fashion relative to
patient characteristics. Before testing for SNPs, samples were
3https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.
html
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anonymized, and a unique randomly generated identification
code was assigned to each record and to the correspondent swab.
Researchers performing genetic analyses were unable to identify
patients at all stages, and no permanent record linking these data
to patient IDs was produced.
Statistical Analysis
Statistical analyses were carried out by researchers not involved
in the dataset storage and management. Calculation of the sample
size was not performed a priori, the ultimate size being equal to
the number of patients recruited during the entire study period.
Continuous variables are presented as median and interquartile
range (IQR) and categorical variables are expressed as number of
patients (percentage).
For the purpose of most analyses, especially in relation
to SNPs, patients were categorized into two main groups:
mild disease (including those left isolated at home isolation
and those hospitalized without complications) and severe
disease (patients hospitalized for intensive/critical care and
patients who died during the observation period, regardless of
initial allocation).
Due to the presence of some missing data, the distribution of
data over the age subgroups is based on the data available for each
variable, while the remaining percentages are calculated using the
number of data available for that subgroup. Univariate analysis
was employed to identify variables associated with development
of severe disease. Mann-Whitney rank sum test or ANOVA
test were used to compare non-parametric continuous variables
between age subgroups and patients with or without severe
disease. Chi-square or Fisher exact tests were used for categorical
variables as appropriate.
Multivariable logistic models were built to determine the
association between potential confounders (age and sex) and the
investigated genotypes. Each multivariable model included all
patients in a first phase and only patients aged 65 years or less in a
second phase. Due to the low frequency of some host’s genotypes,
the multivariable models included only one genotype at time. All
statistical tests were two-tailed, and statistical significance was
defined as P ≤ 0.05. The analyses have not been adjusted for
interaction, and given the possibility of type II error, the findings
should be interpreted as exploratory and descriptive. Analyses
were performed using (R Core Team, 2019) R Software analysis
3.6.1 (2019-07-05) (Available at4).
Bioinformatic Analysis
For TLL-1, prediction of specific protease cleavage site
on the target substrate was performed by SitePrediction
(Verspurten et al., 2009). Top 20 predictions ranked by average
score are reported.
Aminoacidic sequence in FASTA format of the target substrate
Spike protein was retrieved from UniProt (accession: P0DTC2)
that contained cleavage site specificity for members of the
M12.016 sub-family (Rawlings et al., 2018).
4https://www.r-project.org/
RESULTS
Main features of 383 COVID-19 patients included in the study
are summarized in Table 1. Overall, patient M/F ratio was 1.18
and median age was 58 years (IQR = 44–74 years), with a high
percentage of subjects aged 41 to 64 years (39.95%). A total of 148
(38.64%) patients were hospitalized and 32 (8.36%) died during
the follow-up period. Overall, 330 patients were classified as mild
disease and 53 as severe disease.
The distribution of gene polymorphisms in the entire
population is reported in Table 2. One of the five investigated
polymorphisms had an uncommon genotype (TT in TLL-1
rs17047200; N = 11, 2.96%), whereas low frequency genotypes
were found in IFNL3 rs12979860 (TT N = 41, 10.7%), INFL4
rs368234815 (DG/DG 34, 11.30%), MERTK rs4374383 (AA in 44,
15.12%), and PNPLA3 rs738409 (GG 29, 7.82%), respectively. No
significant difference was found between the expected frequency
of these genotypes in the general Caucasian population (Phan
et al., 2020) and that observed in our COVID-19 cohort.
In the whole COVID-19 cohort the distribution of the
genotypes of IFNL3, IFNL4, MERTK and PNPLA was in accord
to the Hardy-Weinberg equilibrium, while the allelic distribution
of the TLL-1 variant rs17047200 (A > T) (Table 3) showed a
statistically significant divergence from Hardy Weinberg since
the number of TT homozygotes observed was higher (11)
than expected (6.3).
Assessment of risk factors associated to a severe outcome
is reported in Table 4. Male subjects and older patients were
significantly at higher risk for a severe outcome (p = 0.02 and
p < 0.001, respectively). In the entire cohort, none of the host’s
SNPs was associated with COVID-19 severity of disease. When
considering only patients aged 65 years or less, two genotypes
were found to be significantly associated to an increased risk of
TABLE 1 | General features of the patient cohort (N = 383).
Sex, N (%)
- F 176 (45.95)
- M 207 (54.05)
Age, N (%)
- 0–18 12 (3.13)
- 19–40 66 (17.23)
- 41–64 153 (39.95)
- 65–74 60 (15.67)




- Yes 148 (38.64)
- No 235 (61.36)
Clinical outcome, N (%)
- Home isolation 234 (61.10)




- Death 32 (8.36)
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TABLE 2 | Distribution of host’s gene polymorphisms in the study cohort.





C > T (N = 383)
- CC 159 41.51% 47.61%
- TC 183 47.78% 42.78%
- TT 41 10.70% 9.61%
MERTK
rs4374383 G > A*
(N = 291)
- AA 44 15.12% 15.21%
- GA 142 48.80% 47.58%
- GG 105 36.08% 37.21%
INFL4
rs368234815
TT/DG* (N = 301)
- DG/DG 34 11.30% 9.61%
- TT/DG 144 47.84% 42.78%
- TT/TT 123 40.86% 47.61%
PNPLA3 rs738409
G > C* (N = 298)
- CC 199 54.64% 59.29%
- CG 143 38.54% 35.42%
- GG 29 7.82% 5.29%
TLL1 rs17047200
A > T*(N = 371)
- AA 285 76.82% 75.69%
- AT 75 20.22% 22.62%
- TT 11 2.96% 1.69%
*Not assessed in all subjects.
TABLE 3 | Genotype distribution for TLL-1 rs10747200 in respect to
Hardy-Weinberg equilibrium.
Genotypes Observed Expected
Homozygote AA 285 280.3
Heterozygote 75 84.3
Homozygote TT 11 6.3
Variant Allele Frequency: 0.13; X2 = 4.532; X2 Test p value = 0.0332.
severe outcome: GG for PNPLA3 rs738409 (p = 0.035) and TT
for TLL-1 rs17047200 (p = 0.029), respectively.
These associations were confirmed by the multivariable
logistic regression analyses performed on patients aged 65 years
or less. After adjustment for sex, an adj-OR of 4.69 (95% CI 1.01–
22.04) was observed for GG in PNPLA3 rs738409 and an adj-OR
of 9.1 (95% CI 1.45–57.3) for TT in TLL-1 rs17047200 (Table 5).
In silico analysis showed that there are at least 20 cleavage sites
on the Spike protein substrate for the TLL-1 protease activity,
confirming that TLL-1 is potentially involved in the Spike protein
cleavage (Table 6).
DISCUSSION
We have used, for the first time to our knowledge in the field of
SARS-CoV-2, nucleic acid extracts generated from swabs during
the diagnostic processing COVID-19 to evaluate the host’s genetic







Sex, N (%)* -F 16 (9.1) 160 (90.9) 0.02
-M 37 (17.9) 170 (82.1)
Age, median (IQR) 75 (67–79) 55 (42–71) <0.001
IFNL3 rs12979860
C > T, N (%)
CC 24 (15.1) 135 (84.9)
TC 24 (13.1) 159 (86.9) 0.82
TT 5 (12.2) 36 (87.8)
MERTK rs4374383
G > A, N (%)*
AA 7 (15.9) 37 (84.1)
GA 25 (17.6) 117 (82.4) 0.78
GG 15 (14.3) 90 (85.7)
INFL4 rs368234815
TT/DG, N (%)*
DG/DG 4 (11.8) 30 (88.2)
TT/DG 21 (14.6) 123 (85.4) 0.61
TT/TT 22 (17.9) 101 (82.1)
PNPLA3 rs738409
G > C, N (%)*
CC 33 (16.6) 166 (83.4)
CG 17 (11.9) 126 (88.1) 0.30
PNPLA3 rs738409
G > C, N (%)*
GG 2 (6.9) 22 (93.1)
CC 33 (16.6) 166 (83.4) 0.17
CG or GG 19 (11.1) 153 (88.9)
PNPLA3 rs738409
G > C, N (%)*
(only ≤ 65 years old
patients)
CC 10 (8.4) 109 (91.6) 0.035
CG or GG 2 (1.8) 109 (98.2)
TLL1 rs17047200
A > T, N (%)*
AA 39 (13.7) 246 (86.3)
AT 9 (12) 66 (88) 0.11
TT 4 (36.4) 7 (63.6)
TLL1 rs17047200
A > T, N (%)*
TT 4 (36.4) 7 (63.6) 0.053
AA or AT 48 (13.3) 312 (86.7)
TLL1 rs17047200
A > T, N (%)*
(only ≤ 65 years old
patients)
TT 2 (33.3) 4 (66.7) 0.029
AA or AT 9 (4.1) 208 (95.9)
*Not assessed in all subjects.
profile. This approach, originally devised for other respiratory
viruses, had suggested that the IFN lambda system could be a
determinant of the outcome of such infections (Rugwizangoga
et al., 2019). Albeit we could not find any significant relation
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TABLE 5 | Multivariable logistic regression models on risk factors associated with
severe outcome (death or critical/intensive care hospitalization).
Odds Ratio 95% CI p-Value
Model 1 (all patients)
TLL1 TT vs. (AA or AT) 3.10 0.73–13.2 0.12
SEX (M vs. F) 3.01 1.49–6.05 0.002
AGE (by year of increase) 1.06 1.04–1.09 <0.0001
Model 2 (all patients)
PNPLA3 rs738409 CC vs. (CG
or GG)
1.45 0.75–2.78 0.27
SEX (M vs. F) 3.14 1.57–6.29 0.012
AGE (by year of increase) 1.06 1.04–1.08 <0.0001
Model 3 (patients
aged ≤ 65 years)
TLL1 TT vs. (AA or AT) 9.1 1.45–57.3 0.018
SEX (M vs. F) 2.13 0.55–8.3 0.275
Model 4 (patients
aged ≤ 65 years)
PNPLA3 rs738409 CC vs. (CG
or GG)
4.69 1.01–22.04 0.049
SEX (M vs. F) 2.12 0.54–8.4 0.269
between the IFN lambda system and the outcome of COVID-
19, the perspective of using genetic material obtained from swabs
could be of major relevance for wide, population-based studies
of the genetic background of people infected by SARS-CoV-
2. In the unresolved pathogenetic scenery of COVID-19, the
individuation of genetic variants associated with more prolonged
course or with a severe outcome of infection, would support
the development of predictive tools useful to stratify subjects
by risk class at presentation. Moreover, the individuation of
key genes could contribute to a better understanding of the
pathways involved in the pathogenesis, giving the basis for
rational therapeutic approaches.
As already widely reported, old age and, to a lesser degree,
male sex were major determinants in the prognosis of COVID-
19 also in our cohort (Onder et al., 2020). Due to unreliability of
data sources, we cannot comment on the role of comorbidities
in this group. Most comorbidities in the general Italian
population are, however, likely to be prevalent in the last
decades of life (Italian National Institute of Statistics, 2020.
Available at5).
Generally speaking, subjects beyond 65 years of age had a
seven-fold risk of developing a severe outcome of COVID-19
than their younger counterpart. Moreover, in older patients the
presence of comorbidities could represent a confounding factor
in identifying other risk factors, as genetic polymorphisms, with
weaker associations.
In this setting, the role of other predisposing factors to disease
severity, including host’s genetic, is likely to be offset. By converse,
in the younger age group, where demographic variables and
comorbidities are less prominent, some of the explored host’s
polymorphisms of genes linked to innate inflammatory response
(PNPLA3) and proteolytic activities (TLL-1) were significantly
associated to the worst outcome of COVID-19.
5https://www.istat.it/it/files/2017/09/Condizioni_Salute_anziani_anno_2015.pdf
TABLE 6 | Top 20 cleavage sites predicted with SitePrediction ranked by average score.









1 319 to 326 RVQP.TESI 36.6 kD 104.6 kD 0.003 37.500 QLQKDENI 0.116 >99%
2 401 to 408 VIRG.DEVR 45.8 kD 95.3 kD 0.002 31.111 FYRADQPR 0.058 >99%
3 634 to 641 RVYS.TGSN 71.6 kD 69.6 kD 0.002 26.190 RSYSDRGE 0.054 >99%
4 219 to 226 GFSA.LEPL 25.5 kD 115.6 kD 0.001 40.000 GEAATSPM 0.028 >99%
5 91 to 98 YFAS.TEKS 10.7 kD 130.5 kD 0.001 24.444 YYRADDAN 0.025 >99%
6 990 to 997 EVQI.DRLI 109.9 kD 31.3 kD 0.000 42.105 QLQKDEVI 0.021 >99%
7 1255 to 1262 KFDE.DDSE 139.5 kD 1.7 kD 0.000 42.500 EFTEDQAA 0.017 >99%
8 685 to 692 RSVA.SQSI 76.9 kD 64.2 kD 0.001 16.667 RSYSDRGE 0.015 >99%
9 493 to 500 QSYG.FQPT 56.2 kD 84.9 kD 0.000 30.000 PYYGDEPM 0.008 >95%
10 254 to 261 SSSG.WTAG 29.3 kD 111.9 kD 0.000 35.000 SYAADTAG 0.005 >95%
11 673 to 680 SYQT.QTNS 75.6 kD 65.6 kD 0.000 32.500 SYAADTAG 0.005 >95%
12 983 to 990 RLDK.VEAE 109.1 kD 32.1 kD 0.000 23.684 QLQKDEVI 0.005 >95%
13 545 to 552 GLTG.TGVL 61.9 kD 79.3 kD 0.000 20.000 GEAATSPM 0.005 >95%
14 937 to 944 SLSS.TASA 104.2 kD 36.9 kD 0.000 12.500 SYAADTAG 0.004 >95%
15 787 to 794 QIYK.TPPI 88.0 kD 53.1 kD 0.000 28.947 QLQKDEVI 0.004 >95%
16 863 to 870 PLLT.DEMI 96.3 kD 44.8 kD 0.000 42.105 QLQKDEVI 0.003 >95%
17 659 to 666 SYEC.DIPI 74.2 kD 66.9 kD 0.000 26.667 FYRADQPR 0.003 >95%
18 839 to 846 DCLG.DIAA 93.7 kD 47.4 kD 0.000 20.000 EFTEDQAA 0.003 >95%
19 416 to 423 GKIA.DYNY 47.4 kD 93.8 kD 0.000 34.043 GMVGDDPY 0.003 >95%
20 248 to 255 YLTP.GDSS 28.8 kD 112.3 kD 0.000 24.444 YYRADDAN 0.003 >95%
The amino acid sequence of Spike protein from UniProt was used as substrate while 17 known cleavage sites for TLL1 were retrieved from MEROPS. Each row represents
a cleavage site within Spike protein together with its position and site.
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Although no precise pathogenetic pathway can be defined
by these observations, some issues deserve considerations. Viral
infections are detected by the host innate immune system using
pattern recognition receptors (PRRs) activated by pathogen-
associated molecular patterns (PAMPs) leading to interferon
(IFN) signaling induction. Type III IFNs or lambda IFNs use
a heterodimeric receptor (IFNLR1-IL10R2) mainly expressed
on the epithelial cells. As proof of the key role type III
IFNs in the regulation of immunity response, single nucleotide
polymorphisms in genes IFNLs were strongly associated with
outcomes to viral infection (Hemann et al., 2017). It has
been reported that the homozygosity for IFNL3 (rs12979860)
and IFNL4 (rs368234815) variants, overrepresented in African
descent, is associated with a reduction of viral clearance in
children affected by acute respiratory infections sustained by
Rhinovirus and Coronavirus (Rugwizangoga et al., 2019). Since
subjects with rs12979860 CC and rs368234815 TT haplotype
were reported to be more effective in clearing RNA viruses,
possibly due to an up-regulation of inflammatory pathways, we
aimed to assess whether the outcome of SARS-CoV-2 infection
is conditioned by these polymorphisms. Our results suggest
that the polymorphic status of IFNL3/IFNL4 does not affect
the rate of infection, since the genotypes are fully in Hardy-
Weinberg equilibrium, nor the likelihood of a severe outcome
of COVID-19. Hence the suggestion about using IFNLs as an
antiviral in COVID-19 patients or in subjects at high risk of
infection, currently in clinical trials with peg-IFN L1, would not
be supported (Prokunina-Olsson et al., 2020).
COVID-19 pneumonia is characterized by inflammatory
exudation of monocytes and lymphocytes. Lung tissues show an
abnormal accumulation of CD4 + helper T lymphocytes and
CD163 + M2 macrophages recruited by type II pneumocytes
in the alveolar spaces. The immunohistochemical evidence,
showing strong positivity and site-specific expression, suggest
that M2 macrophages play a key role in COVID-19 pathogenesis
(Zeng et al., 2020). Mer tyrosine kinase (MERTK) is a major
macrophage receptor involved in the clearance of apoptotic cells
expressed principally in the subpopulation of M2 macrophages
(Zizzo et al., 2012). The polymorphic status of the MERTK
gene is able to influence its expression, conditioning M2
polarization of resident macrophages. Genotyping of our patients
show that the polymorphic assessment for MERTK does not
affect neither the rate of infection, the genotypes being in
Hardy-Weinberg equilibrium, nor the likelihood of a severe
outcome of COVID-19.
The patatin-like phospholipase domain-containing 3
(PNPLA3) is a triacylglycerol lipase, which mediates
triacylglycerol hydrolysis in adipocytes. The PNPLA3 missense
variant rs738409 (Ile148Met) (C > G), causing loss of function,
is associated with hyperexpression of the NLRP3 inflammasome,
leading to increased serum levels of IL-1β and IL18 (Mitsuyoshi
et al., 2017). It is known that many viruses and among them
SARS-CoV-2, are directly able to induce activation of the
NRLP3 inflammasome leading to the cytokines storm probably
causing most fatal outcomes (Farag et al., 2020). In our sub
cohort of patients ≤ 65 years, the GG PNPLA3 genotype was
significantly associated to an increased risk of severe outcome.
It is thus conceivable that subjects carrying the GG genotype
for rs 738409, having a constitutive upregulation of the NLRP3
inflammasome, develop more severe tissue damage when
infected by SARS-CoV-2.
Tolloid Like 1 (TLL-1) is a gene encoding an astacin-like,
zinc-dependent, metalloprotease that belongs to the peptidase
M12A family. The TLL-1 intronic variant rs17047200 (A > T)
was described, for the first time, in 2017 as associated with
development of hepatocellular carcinoma after eradication of
hepatitis C virus infection (Matsuura et al., 2017). Using in silico
approach we found that near TLL1 gene maps the Intergenic
Long Non-Coding (LINC01179) able to work as an element in cis
to regulate the gene expression. We evaluate if the polymorphic
status relatively to rs17047200 (A > T) of TLL-1 gene is related to
the outcome in SARS-Co-V-2 patients. We found that the allelic
distribution in our cohort for this SNP is not consistent with
Hardey-Weinberg equilibrium being the number of homozygotes
TT observed higher (11) respect to the expected (6,3) (Table 3).
In addition, the TT genotype in patients aged 65 years or less was
found to be significantly associated to an increased risk of severe
outcome (p = 0.029). This data suggests that the homozygosity TT
could be related not only with the occurrence of severe outcome
but also with a higher rate of infection. The possible explanation
is related to the TLL-1 catalytic domain which shows a relative
promiscuity, and many TLL-1 substrates are known. The spike
protein (S), a trimeric transmembrane protein of the SARS-CoV-
2, after cleavage of the ectodomain, is essential for viral binding
and entry into the host cells using the receptor angiotensin
converting enzyme 2 (ACE2). The cleavage of S into subunits
represents the fundamental step for viral entry in uninfected
cells, and SARS-CoV-2 has developed several strategies for
proteolytic activation using a large number of host proteases.
Among them, furin, trypsin, trans-membrane protease/serine
(TMPRSS) which cleave S in Golgi apparatus or during virus
endosomal uptake, and cathepsins which cleave S during virus
entry (Sun et al., 2020). A role of the interaction between
complement defense collagens C1q and mannose-binding lectin
with TLL-1 in triggering the activation of complement during
inflammation and tissue repair has also been described (Lacroix
et al., 2017). Among our younger patients, homozygosity for the
TT genotype was significantly associated to an increased risk of
severe outcome, at a lesser strength than PNPLA3 and further
study are needed to understand the mechanism at the bases
of this evidence.
Albeit these data suggest that SNPs for PNPLA3 and for
TLL-1 may modulate the course of SARSCoV-2 infection, we
must acknowledge some limitations of our study. The enrolment
cohort was limited in sample size, thus possibly preventing some
of the uncommon SNPs to reach significance due to the small
number of patients with each variant. Along the same line,
the relatively low number of unfavorable outcomes may have
curtailed the significance of some allelic variants. The modality
of accrual of the cohort through a referral laboratory may have
originated some selection and information retrieval biases, and
an external validation group has not been tested. Last but not
least, a whole genome sequencing approach, rather than a spot
evaluation of some individual parameters, would have originated
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more information. The latter approach, although desirable, was
made impossible by the lockdown phase at the time when the
study was performed at our Institution.
Patients in our cohort were collected during the early phase
of local spreading of the infection, at a time when pre-
existing immunity in the general population can be estimated
to be non-existent. In this group, the distribution of the low
frequency GG genotype distribution of PNPLA3 rs738409 was
in accord to the Hardy-Weinberg equilibrium. When assessing
whether the polymorphic status of rs17047200 (A > T) of
the TLL-1 gene is related to the outcome of COVID-19
patients, we found that the allelic distribution in our cohort
for this SNP was not entirely consistent with the Hardy-
Weinberg equilibrium, suggesting a possible predisposing role
to SARS-CoV-2 infection. Over the last weeks of the first
wave, there has been a diffuse, albeit yet unsubstantiated,
feeling that the clinical expression of COVID-19 has become
less aggressive, and that new cases occurring in areas where
SARS-CoV-2 was still actively spreading were less severe.
It is unclear whether this was due to an attenuation of
viral pathogenicity, to environmental factors or to population
characteristics. Whilst the reported low number of deaths due
to COVID-19 in our region cannot cause a reduction in
the number of subjects with the “unfavorable” genotype, a
further unfavorable evolution of the pandemics would possibly
cause a reduction in the number of subjects carrying it
(Ledda et al., 2021).
In conclusion, we feel that polymorphisms of the host’s
genetic determinants, and especially those related to the
innate inflammatory response to SARS-CoV-2, should be
carefully assessed by a wide-ranging approach, aiming to
develop gene profiling tools in order to support an early
prediction at the individual level in the course of COVID-19.
If host’s polymorphisms are confirmed as determinants of
severity, new strategies for identifying vulnerable populations
or patients at higher risk for severe disease could be
implemented and promoted, improving diagnosis, treatment and
prognosis of COVID-19.
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